BRTX-100 is the first and only stem cell product candidate cleared to be evaluated in the cervical degenerative disc disease setting –– IND ...

In the meantime, we continue to advance our FDA Fast Track-designated BRTX-100 chronic lumbar disc disease (cLDD ... The commonly affected levels are C5/C6 and C6/C7, with C7 being the most ...